Percutaneous Repair of Paravalvular Leaks After TAVR: The Challenge of Identifying Eligible Subjects

Courtesy of Dr. Carlos Fava.

Percutaneous Repair of Paravalvular Leaks After TAVRThis study enrolled 72 patients who underwent transcatheter aortic valve replacement with an Edwards Sapiens valve, and then experienced a leak of at least moderate severity.

 

Fifteen of them underwent a percutaneous leak repair after identification of the leak mostly through the presence of symptoms.

 

Both groups were similar. Patients who underwent percutaneous repair were younger. Plugs were used in the repair, and no patient experienced hemolytic anemia.

 

The procedure was successful in 13 patients. In 2 of them, crossing of the leak was impossible to achieve. One patient who continued experiencing symptoms required a new intervention.

 

At 20 months of follow-up, there was 1 (13.8%) death in the group of patients who underwent a leak repair and 24 (42%) deaths in the control group. Leak repairs benefited patients, who experienced improvement in symptom status, reduction in subsequent hospitalizations, and reduction in B-type natriuretic peptide levels.

 

Conclusion

Transcatheter repair of paravalvular leaks after TAVR can be safe and effective in a selected patient group and may lead to reductions in hospitalizations, and improvement in symptoms and long-term survival.

 

Editorial Comment

Paravalvular leaks with current technology occur in 13%-15% of cases and are one of the technological challenges to be worked out in the future.

 

In these cases, identifying patients eligible for this procedure is of the utmost importance, since leaks can be repaired safely and effectively, improving quality of life and long-term survival.

 

Courtesy of Dr. Carlos Fava. Buenos Aires Favaloro Foundation, Argentina.

 

Title: Outcome of Paravalvular Leak Repair After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prothesis.

 Reference: Abhijeet Dhoble, et al. Catheterization and Cardiovascular Interventions 2017;89:462-468.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....